Clinical trial

Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Biliopancreatic…

NCT00327912 · Göteborg University, Other · Unknown status

Key facts

NCT number NCT00327912
Title Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Biliopancreatic Diversion (BPD)- Duodenal Switch for Superobesity
Official title Laparoscopic Roux-en-Y Gastric Bypass vs. Laparoscopic BPD-Duodenal Switch for Superobesity (BMI > 50 kg/m2)- A Randomized Clinical Trial
Acronym ASGARD
Lead sponsor Göteborg University, Other
Collaborators Helse Sor-Ost
Status Unknown status
Phase Phase 4
Study type Interventional
Conditions Obesity, Diabetes, Hypertension
Intervention type Procedure
Interventions Laparoscopic Biliopancreatic diversion with Duodenal switch, Laparoscopic Roux-en-Y Gastric Bypass
Enrollment 60
Start date Apr 1, 2006
Primary completion Dec 1, 2017
Completion Dec 1, 2017
First posted May 19, 2006
Last update posted Feb 2, 2017
Countries Norway, Sweden

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies